Wikidata

(Q66033733)

English

Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer

clinical trial

In more languages

Statements

title
A Randomized, Open-Label, Phase III Study of RPR109881 IV Every 3 Weeks Versus Capecitabine (Xeloda) Tablets Twice Daily for 2 Weeks in 3-Week Cycles in Patients With Metastatic Breast Cancer Progressing After Taxanes and Anthracycline Therapy (English)
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Brazil
0 references
Canada
0 references
Chile
0 references
Colombia
0 references
Czech Republic
0 references
Finland
0 references
France
0 references
Germany
0 references
Hungary
0 references
Israel
0 references
Italy
0 references
Mexico
0 references
New Zealand
0 references
Poland
0 references
Portugal
0 references
Romania
0 references
Slovenia
0 references
South Africa
0 references
Spain
0 references
Taiwan
0 references
United Kingdom
0 references
start time
April 2004
0 references
end time
September 2006
0 references
number of participants
438
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q66033733&oldid=1858594514"